3TC (Lamivudine, Epivir): Archive 1995-1997
- d4T and 3TC Combination Studies Confirm the Effect of the Combination (January 1997)
In The 4th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Final Results of CAESAR Study Demonstrate a Survival Benefit with 3TC (January 1997)
In The 4th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- 3TC Clinical Benefit: More Data Presented (October 4, 1996)
In AIDS Treatment News, from AIDS Treatment News
- 3TC: Glaxo Wellcome Broadens Patient Assistance (June 7, 1996)
In AIDS Treatment News, from AIDS Treatment News
- California: 3TC Now Available Through ADAP (May 3, 1996)
In AIDS Treatment News, from AIDS Treatment News
- San Francisco: 3TC Available Now to Residents Through ADAP Program (April 5, 1996)
In AIDS Treatment News, from AIDS Treatment News
- Profiles on New Drugs (March 1996)
In Moore News for Care Providers, from Johns Hopkins AIDS Service
- Approvals for 3TC, Saquinavir (December 1995)
In TAGline, from Treatment Action Group
- Lamivudine Approved for Combination Use with AZT (December 1, 1995)
In AIDS Treatment News, from AIDS Treatment News
- 3TC: Now Available Again Up to CD4 of 300 (August 4, 1995)
In AIDS Treatment News, from AIDS Treatment News
